New Evernorth data shows more Americans seeking prescription treatment earlier – reshaping demand across pharmacies, clinicians, and virtual care.
Evernorth Precision Path improves cancer care from diagnosis through survivorship by enabling earlier screening, faster treatment, and coordinated support. With 24/7 access to a multidisciplinary care team, Precision Path reduces provider burden, ER visits, and overall costs—while improving outcomes across the cancer journey.
The introduction of a new generic medication to prevent the spread of HIV improves affordability – but only if plan sponsors encourage use and adherence.
Accredo pharmacist Janet Kohli, who specializes in supporting patients with advanced pulmonary conditions, shares how she guides patients through complex therapies with empathy, expertise, and coordinated, personalized support.
Bills currently moving through the Tennessee state legislature could cut off access to medicine for families, active-duty military members and more, while disrupting care for more than 180,000 Tennesseans.
A $0 copayment makes it easier for military families living far from military facilities to get the medications they need.
Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology
As new cancer diagnosis shifts toward younger working‑age employees, employers need updated approaches to upstream prevention, early detection, benefit design, care navigation, and survivorship support.